Corporate Banner
Satellite Banner
Genotyping & Gene Expression
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bionest Partners and Scisive Consulting Merge

Published: Tuesday, January 29, 2013
Last Updated: Tuesday, January 29, 2013
Bookmark and Share
The merged companies will operate under the name of Bionest Partners with offices in New York, Paris, London and San Diego, with presence in Munich and Tokyo.

Success in today’s competitively evolved medical industry requires insightful strategy informed by operating practicalities. Bionest Partners has combined with Scisive Consulting to create a new model consulting firm intensely responsive to, and highly qualified for, the planning needs of a new generation of medical business leaders and investors. This fusion of two highly-respected medical business consultancies equips us to deal with the new demands of the medical marketplace, and also enables each to augment its intellectual capital and expand its geographic coverage.

Bionest Partners’ new senior management team will be Alain J. Gilbert and Bob J. Easton, as Co-Chair, together with partners Dr. Mary Koto, Catharine Staughton, Olivier Lesueur and Dr. Sean Hu, offering:

•    Complementarity of leadership, at once Strategic with Bob J. Easton and Operational with Alain J. Gilbert, to guarantee our clients "Practical Operability" of our recommendations
•    Broader sector and deeper functional expertise: drugs/devices/diagnostics (including personalized medicine); research/development/marketing/planning/pricing/corporate development
•    Personalized Medicine Strategy, widely recognized consulting expertise
•    Geographic reach, with offices in Paris, London, New York, San Diego and affiliates in Munich and Tokyo

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
NIH Supports New Studies to Find Alzheimer’s Biomarkers in Down Syndrome
Initiative will track dementia onset, progress in Down syndrome volunteers.
New Gene Map Reveals Cancer’s Achilles’ Heel
Team of researchers switches off almost 18,000 genes
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos